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Temporal Response of Rabbits to 6-Adrenergic Agonist Feeding:
Tissue Weight, Calpains and Calpastatin Activities, and
Nucleic Acid and Protein Concentrations112
T. D. Pringle*, S. M. Lonergan*, C. R. Calkins*, S. J. Jones*,
P. S. Miller*, and M. Koohmaraiet
*Department of Animal Science, University of Nebraska, Lincoln 68583-0908 and
?Roman L. Hruska U.S. Meat Animal Research Center, ARS, USDA, Clay Center, NE 68933-0166

ABSTRACT:
Forty-eight crossbred rabbits were
used in three replications of a 2 x 4 factorial
arrangement to investigate the short-term responses
of tissue accretion, calpains and calpastatin activity,
and nucleic acid and protein concentrations to 6adrenergic agonist (BAA) feeding. Rabbits were fed a
17% CP diet with or without 7 ppm of L644,969and
slaughtered after 1, 4, 8, or 16 d of treatment. Empty
body dressing percentage and biceps femoris weight
( a s a percentage of empty body weight [EBWI) were
significantly higher in the treated rabbits than in the
controls after 16 d of treatment. Heart and liver
weights ( a s a percentage of EBW) were higher ( P <
.05) after 1 d and liver weight ( a s a percentage of
EBW) was lower ( P < .05) after 16 d in treated vs
controls. Except for an elevation of skeletal muscle mcalpain after 16 d, BAA-supplementation did not affect

the calpain-calpastatin system. Muscle RNA concentrations and RNA:DNA ratios were higher ( P < . 0 5 ) in
treated rabbits after 1 d and remained higher
thereafter. Protein:RNA ratios were lower ( P < .0 1)in
treated than in control rabbits after 4 d and remained
lower throughout the trial. Muscle DNA content was
lower after 4 d and higher after 16 d; RNA content
was higher after 4, 8, and 16 d; and protein content
was higher after 16 d in treated vs control rabbits.
Liver nucleic acid and protein concentrations were not
affected by BAA treatment. Heart RNA:DNA ratios
were higher ( P < .0 1) after 1 d and protein:RNA
ratios were lower ( P < .05) after 4 d in the treated
rabbits than in the controls. Collectively, these data
imply that BAA-induced muscle growth in rabbits
occurs through hyperplasia and seems to be related to
elevated protein synthetic capacity.
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Introduction
0-Adrenergic agonists ( BAA) are adrenomimetic
compounds known to increase muscle growth under a
variety of physiological conditions (for reviews see
Mersmann, 1989; Yang and McElligott, 1989; Anderson et al., 1991). These compounds also affect other
organs. Heart weight is increased in rats (Reeds et al.,
1986) and rabbits (Forsberg et al., 1989), decreased
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in sheep (Kim et al., 1987) and cattle (Moloney et al.,
1990), and remains unchanged in swine (Cromwell et
al., 1988) treated with BAA. Conversely, liver weight
is generally decreased by chronic BAA treatment
(Reeds et al., 1986; Williams et al., 1989; Moloney et
al., 1990; Muramatsu et al., 1991).
The mechanism for BAA-induced muscle growth
has been studied extensively and may vary depending
on the compound and species studied. The BAAresponse in skeletal muscle growth has been partially
attributed to decreased protein degradation (Reeds et
al., 1986; Bohorov et al., 1987; Bardsley et al., 1992;
Wheeler and Koohmaraie, 1992). This decrease seems
to be related to alterations in the calpain proteinase
system, particularly through elevation of calpastatin
activity (Kretchmar et al., 1989; Koohmaraie et al.,
1991; Bardsley et al., 1992; Wheeler and Koohmaraie,
1992; Pringle et al., 1993). This elevation occurs
within 2 wk of treatment in lambs and is maintained
with subsequent treatment (Pringle et al., 1993).
Because the calpain system is found in both cardiac
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and hepatic tissues (Murachi et al., 1981), it is
possible that the BAA-response of these tissues occurs
through a mechanism similar to that in skeletal
muscle. Therefore, this experiment was designed to
investigate the mechanism(s1 for the short-term
responses of rabbit skeletal muscle, heart, and liver to
BAA treatment.

Experimental Procedures
Experimental Design. Forty-eight doe rabbits (New
Zealand White x California White; Elmwood Rabbit
Production, Elmwood, NE) were assigned to three
replicates of a 2 x 4 factorial arrangement, with two
treatments (control and treated) and four slaughter
end points ( 1 , 4, 8, and 16 d). In addition, two rabbits
were slaughtered a t the initiation of each replicate to
establish baseline values for the variables measured
( n = 6 ) . All housing, handling, and experimental
procedures were approved by the University of
Nebraska-Lincoln Institutional Animal Care and Use
Committee. Upon delivery, the rabbits were ranked by
weight, divided into groups of nine (including the
initial slaughter group), and assigned to the nine
treatments. The rabbits were individually housed and
conditioned to their diets and surroundings for 10 to
14 d before initiation of each replicate, receiving ad
libitum access to feed3 and water containing 1.3%
(vol/vol) of a coccidiostat (Albon; Roche, Nutley, NJ).
The control rabbits had ad libitum access to water
and feed, along with 5 g of molasses, top-dressed daily
on the diet. The treated rabbits received the same diet
with the equivalent of 7 ppm of the P-adrenergic
agonist L644,969added to the molasses. The rabbits
were weighed on two consecutive days to start each
replicate and once a t assigned slaughter times ( 1 , 4 , 8 ,
and 16 d). After weighing, the rabbits assigned to that
slaughter end point were lightly anaesthetized with
COz and killed by decapitation. Blood was collected for
determination of urea nitrogen. Within 30 min postmortem, a randomly selected hindlimb of each rabbit
was skinned and the biceps femoris muscle was
removed intact and weighed. The abdominal and
thoracic cavities were opened and the liver and heart
were removed and weighed. After weighing, tissues
were minced and sampled fresh ( 5 g ) for determination of calpains and calpastatin activities. The remainder of the tissue was frozen at -70°C and stored
for measurement of nucleic acid and protein concentrations. Because of small size, hearts were pooled for
the two rabbits in each treatment at each slaughter
end point, before sampling. Because the rabbits had
access to feed and water immediately before slaughter,

3 ~ u r i n a ' Rabbit chow' Performance Blend, a pelleted feed
containing > 17.0% CP, 2.0% crude fat, 18.0%crude fiber, and 8.0%
ash.
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empty body weight ( EBW) was measured to minimize
the variation caused by gastrointestinal fill. After
tissue sampling, each full gastrointestinal tract was
weighed, emptied, blotted dry, and reweighed. Empty
body weight included the empty gastrointestinal tract.
Within 10 h postmortem, carcasses were skinned,
washed, weighed, and stored at -20°C.
Determination of Calpain and Calpastatin Activity.
Activities of the calpains and calpastatin were determined on unfrozen, prerigor skeletal muscle, heart,
and liver samples according to the procedures of
Koohmaraie (1990) with the following modifications.
Tissue samples ( 5 g ) were homogenized in 2.5
volumes of extraction buffer (100 mM Tris, 5 mM
EDTA, and 10 rnM 0-mercaptoethanol [MCEI, pH
8.3), centrifuged, filtered, and dialyzed overnight
(molecular weight cutoff 12,000 to 14,000) in buffer
(20 mM Tris, 5 rnM EDTA, and 10 mM 0-MCE, pH
7.5). The dialyzed samples were centrifuged, filtered,
loaded onto anion exchange (DEAE-Sephacel; Sigma
Chemical, St. Louis, MO) columns (1.5 cm x 20 cm;
Bio-Rad, Richmond, CA), and washed with three to
five column volumes of elution buffer (20 mM Tris, .l
mM EDTA, and 10 mM 0-MCE, pH 7.35). The
samples were eluted using a linear NaCl gradient in
elution buffer ( 0 to 350 mM, total volume 500 mL for
skeletal muscle; and 0 to 400 mM, total volume 400
mL for heart and liver). For skeletal muscle 150
fractions ( 3 mL) and for heart and liver 130 fractions
( 3 mL) were collected.
Activities of skeletal muscle p- and m-calpain and
heart and liver m-calpain were determined using a
casein solution (100 rnM Tris, 1 mM NaN3, 5 mM
CaC12, 2 & / m L of P-MCE, and 5 mg/mL casein, pH
7.5). One unit of proteinase activity was defined as
the amount of enzyme necessary to cause an increase
of 1.0 absorbance unit at 278 nm. Skeletal muscle
calpastatin activity was determined using the same
casein solution, following the procedures of Koohmaraie (1990). Because of the abundance of calpastatin in heart and liver samples, calpastatin and pcalpain could not be adequately separated. Therefore,
calpastatin activity was measured using the procedure
of Koohmaraie et al. ( 1987). An aliquot ( 2 mL) from
fractions thought to contain calpastatin was heated at
90°C for 4 min and centrifuged (2,000 x g ) to
precipitate the denatured material. The supernatant
volume was recorded and the samples were assayed
for calpastatin as described above with adjustment of
calpastatin activity for changes in volume due to
heating. One unit of inhibitor activity was defined as
the amount of calpastatin necessary to inhibit one unit
of DEAE-purified rabbit lung m-calpain activity. The
various components of the calpain-calpastatin system
eluted from our columns in a manner consistent with
that reported by Wheeler and Koohmaraie (1991).
Nucleic Acid and Protein Concentrations. Tissue
DNA was determined using the fluorogenic intercalating agent Hoechst 33258 (Sigma Chemical, St. Louis,
MO; Labarca and Paigen, 1980). Tissue RNA was
measured spectrophotometrically using the procedures
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of Munro and Fleck ( 1969), and tissue protein was
determined using the biuret procedure of Gornall et al.
(1949). Nucleic acid and protein contents of the
tissues were calculated by multiplying the various
concentrations in the tissues by the weights of the
tissues.
Blood Urea Nitrogen. Blood was allowed to sit
overnight at 4"C, centrifuged (2,500 x g ) for 10 min,
and the serum collected and frozen at -20°C for future
analysis. Blood urea nitrogen was determined according to the procedures of Crocker (19671, using a
Sigma urea nitrogen kit (Sigma Chemical; procedure
#535).
Statistical Analyses. The data were analyzed using
ANOVA for a completely randomized design with
replication (Steel and Torrie, 1980). The treatment
means of treated and control rabbits at specific
slaughter end points, along with linear and quadratic
effects, were compared with single df contrasts using
the interaction of treatment and replication as the
error term. The data are presented as means f SEM.
Different values for SE within a trait are due to
differences in the number of observations for means.

1) was higher in the control than in the BAA-fed
rabbits after 4 d but was similar thereafter. Dressing
percentage and biceps femoris weight ( a s a percentage
of EBW, Table 1 and wet weight, data not shown)
increased linearly in the BAA-fed rabbits and were
higher than those in controls ( P < .05) after 16 d.
Liver weight ( a s a percentage of EBW; Table 1)
increased initially and decreased thereafter in the
BAA group and was higher after 1 d ( P < .05) and
lower after 16 d ( P < .05) in the treated rabbits than
in the controls. Heart weight ( a s a percentage of
EBW; Table 1) was higher in the treated rabbits after
1 d ( P < .01) and returned to control values
thereafter. Blood urea nitrogen was numerically lower
in the treated rabbits after 1 d and remained lower
throughout the study. However, these differences were
not significant ( P > .20; Table 1).
Calpain-Calpastatin System. Except for the activity
of skeletal muscle m-calpain, the calpain-calpastatin
system was not affected ( P > .20) by dietary BAA
administration in the three tissues investigated (Table 2). Skeletal muscle m-calpain activity tended to be
lower ( P < . l o ) after 1 d and was higher ( P < .05)
after 16 d of BAA treatment. The ratios of the two
proteinases and pr0teinase:inhibitor activities in muscle are consistent with other data in rabbits
(Gopalakrishna and Barsky, 1985). The data for the
various tissues are also comparable with earlier
findings (Gopalakrishna and Barsky, 1985; Blomgren
et al., 1989).

Results
Animal Performance and Tissue Weights. Average
daily gain was not affected ( P > .5) by BAA treatment
during the trial (Table 1 ) . Empty body weight (Table

Table 1. Response of final empty body weight, average daily gain, dressing percentage,
and tissue weights to 0-adrenergic agonist (BAA] treatment
Time on feed, d
0

Trait
Empty body wt (EBW), g
Controla

BAA^,^
ADG, g
ControlC
BAA
EBW dressing percentage, 4
Control
BAAC
Biceps femoris wt, 5% of EBW
Control
~-4.4~"
Liver wt, 3' 6 of EBW
Control
BAAC
Heart wt, % of EBW
Control
BAA
Blood urea nitrogen, mg/dL
Control
BAA

1,642.0
1,642.0

+ 47.3

+ 47.3

58.7
58.7

4

1

+
f

1.49 If1.49

+
3.96 +
3.96 +
.28 f
.28 +

82.4
60.4

F 13.5
i 13.5

1,851.1 f 47.3*
1,692.0
47.3

+

16

1,938.4 i 47.3
1,938.7 i 47.3

26.9 f 13.5
31.1
13.5

27.6
39.0

f 13.5
13.5

57.2
58.6

i
i

+

+

2,182.1 f 41.7
2,196.1 f 39.1
29.5 k 12.7
33.1 f 11.9

.9
.9

57.6 F
57.3 i

.9
.9

59.5 f
58.7

.03
.03

1.44 i
1.43 F

.03
.03

1.51
1.50 +

+

.03
.03

1.49 i
1.55 i

.03
.03

1.50 f
1.74

.03"*
.03

.27
.27

3.50 i
4.53 i

.27*
.27

3.66
3.44

+

.27
.27

3.53 i
3.37 i

.27
.27

4.15 f
3.39 f

.24*

.O1
.01

.26 F
31

.01**
.01

.O1
.01

.26 i
.27 i

.01
.01

.26
.27 f

19.4 f 1.7
19.4
1.7

+

1,804.7 i 47.3
1,692.0 k 47.3

8

+

18.3 i 1.7
15.2 i 1.7

+

+
.28 +
.28 +

.9
.9

17.2 f 1.7
1.7
16.4

+

aLinear effect ( P < .01).
b ~ u a d r a t i ceffect ( P < .01).
'Linear effect ( P < .05).
****Means within a trait, a t a specific time, differ ( P < .05 and .0l, respectively).

.9
.9

21.6 F 1.7
19.2 i 1.7

58.5 f
61.2 f

+

+
+

.8*
.8

.22
.01
.O1

19.3
1.5
15.9 i 1.4
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Table 2. Response of biceps femoris (BF),liver, and heart calpains and calpastatin
activities to 0-adrenergic agonist (BAA]treatment
Time on feed, d
Trait

1

0

BF pcalpain, units/ga
Control
BAA
BF m-calpain, units/g
Control
BF calpastatin, units/$'
Control
BAA
Liver calpastatin, units/$'
Control
BAA
Heart calpastatin, units/ga
Control
BAA

8

16

.53 f .08
.53 f .08

.53 f .08
.39 f .08

.41 f .08
.31 f .08

1.09 i .10
1.09
.10

1.15 f .lo'
.88 f .10

1.01 f .10
1.15 f .10

.96f
1.19 f

.10
.10

1.03 f .lo*
1 . 3 8 f .10

4.74 f .60
4.74 f .60

4.14 f
4.67 f

.60
.60

4.04 f .60
5.32 f .60

4.12
3.21

+
+

.60
.70

4.46 f .60
3.75 f .60

8.37 f .60
.60
8.37

6.59 f
7.23 f

.60
.60

6.60 + .60
7.78 f .60

6.95 f .60
6.25 f .60

6.46 f .60
6.38 f .60

9.26 f 1.12
11.08 f 1.12

9.96 + 1.12
9.71 f 1.41

9.78 f 1.12
10.48 + 1.12

10.53 f 1.12
12.41 F 1.12

+

BAA^

4

+

9.46 f 1.12
9.46 f 1.12

.42 f .08
.42 f .08

.52 f .08
.46 f .08

aNo treatment effect ( P > .2).
b ~ i n e a reffect ( P < .01).
t , * ~ e a n swithin a trait, a t a specific time, differ ( P < .10 and .05, respectively).

Nucleic Acids and Protein. Biceps femoris DNA and
protein concentrations and protein:DNA ratios were
not affected by BAA treatment ( P > .5; data not
shown). The RNA concentration and RNA:DNA ratio
were higher in the BAA-fed rabbits than in controls
after 1 d and remained higher throughout the feeding
period (Table 3). The difference between treated and
control rabbits increased to 4 d and then attenuated
with continued BAA administration. Conversely, the
muscle protein:RNA ratio (Table 3 ) in the BAA-fed
rabbits was lower after 4, 8, and 16 d compared with
controls. Primarily because of the advantage in muscle
weights, DNA and protein contents were higher in the
treated rabbit muscle than in the controls after 16 d
(Table 4). The RNA content of the biceps femoris from
BAA-treated rabbits was higher than in controls after
4, 8, and 16 d.
Unlike skeletal muscle, neither liver nor heart
nucleic acid and protein concentrations were affected
( P > .20) by BAA treatment (data not shown). Heart
protein:DNA ratio was higher after 1 d ( P < .05);
RNA:DNA ratio was higher after 1 ( P < .0 1) and 4 d
( P < . l o ) ; and protein:RNA ratio was lower after 4 d
( P < .05). All ratios were similar to controls within 8 d
of treatment initiation (Table 3). Although liver
protein content was not affected by BAA treatment ( P
> .5), both liver DNA and RNA contents were higher
in the treated rabbits a t the conclusion of the study.
Discussion
One of the most consistent responses to BAA
treatment is enhanced muscle growth (Yang and
McElligott, 1989), most prominently in muscles domi-

nated by Type I1 (fast-twitch, glycolytic) fibers
(Beermann et al., 1987). In our study, BAA-treated
muscle weight began to diverge from controls after 8 d
and was significantly higher than controls after 16 d
of treatment.
It is commonly postulated that BAA-induced muscle
growth occurs through a hypertrophic model (Beermann et al., 1987; Kim et al., 1987; Kretchmar et al.,
1989; Koohmaraie et al., 1991; Pringle et al., 1993).
This does not seem to be the case in rabbits. Forsberg
et al. (1989) reported that DNA content was increased in the biceps femoris, extensor digitorium
longus, and gastrocnemius muscles of cimateroltreated rabbits and suggested a mechanism involving
satellite cell incorporation to explain the changes in
muscle growth. 0-Adrenergic agonist treatment has
also increased DNA in transplanted (Roberts and
McGeachie, 1992) and denervated (Maltin et al.,
1989) mouse muscle and caused increased proliferation of cultured chick embryo breast muscle satellite
cells (Grant et al., 1990). However, further investigation of BAA-treated, denervated muscle showed no
increase in DNA, recruitment of satellite cells, or
mitosis (Maltin and Delday, 1992). These researchers
suggested that the increases in DNA content of BAAtreated muscle may be due to proliferation of nonmyofiber cells, as shown by Dumont et al. (1989).
Unfortunately, our procedures for measuring DNA do
not allow separation of myofiber from non-myofiber
DNA. Thus, although biceps femoris DNA content was
increased after 16 d of BAA treatment in this study, it
is not obvious whether these changes were truly
indicative of hyperplastic growth.
Previous work in lambs (Kretchmar et al., 1989;
Koohmaraie et al., 1991; Pringle et al., 1993) and
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Table 3. Response of biceps femoris (BF) and heart RNA concentration and RNA:DNA
and protein:RNA ratios to 0-adrenergic agonist (BAA) treatment
Time on feed. d
Trait

0

1

4

8

16

BF RNA concentration, pg/g
Control

BAA^^

BF RNA:DNA, pglpg
Control
BAA~C
BF protein:RNA, mglmg
Control
BAA~c
Heart RNA concentration, mglgd
Control
BAA
Heart protein:DNA, m d m g
ControlC
BAA
Heart RNA:DNA, mg/mg
Control
BAAe
Heart protein:RNA, mglmg
Control
BAA
aLinear effect ( P < ,011.
b ~ u a d r a t i ceffect ( P < ,011.
CLinear effect ( P < .05).
d ~ treatment
o
effect ( P > ,351.
eQuadratic effect ( P < .05).
?,*,**Means within a trait, a t a specific time, differ ( P < .05 and .01, respectively)

Table 4. Response of biceps femoris (BF) and liver total nucleic acid and protein
contents to a 0-adrenergic agonist (BAA) treatment
Time on feed, d
Trait

0

1

4

BF DNA, mg
Controla

BAA^^

BF RNA, mg
ControlC
BAAa
BF protein, g
Controla

BAA^^

Liver DNA, mg
Control

BAA^^

Liver RNA, mg
ControlC

BAA^

Liver protein, g
Controla
BAAa
aLinear effect ( P < .01).
b ~ u a d r a t i ceffect ( P < .01).
'Linear effect ( P < ,051.
d ~ u a d r a t i ceffect ( P < .05).
+,*-**Means within a trait, a t a specific time, differ ( P < .lo, .05, and .01, respectively).
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cattle (Wheeler and Koohmaraie, 1992) demonstrated
(Kim et al., 1987; Williams et al., 1989) and cattle
(Moloney et al., 1990), and similar weights in swine
a positive relationship between BAA-induced muscle
(Cromwell et al., 1988). In our study, heart weight
growth and calpastatin activity. The majority of the
was
higher after 1 d of BAA treatment and not
BAA-induced alterations in lamb muscle weight and
calpastatin activity occurs within 2 wk of treatment
different from controls thereafter. The change in
initiation (Pringle et al., 1993). Our data suggest that
weight was again independent of significant change in
the enhanced muscle growth of BAA-treated rabbits
the calpain-calpastatin system. The increase in weight
does not require alteration of the calpain-calpastatin
Was accompanied by an increase in cell mass (protein:
system. The only change in the calpain-calpastatin
DNA; Table 31, indicative of hypertrophic growth in
system was an increase in the activity of m-calpain,
BAA-treated cardiac muscle. Heart RNA:DNA ratios
which is consistent with other reports (Kretchmar et
were also significantly higher after 1 d of treatment,
in ~the
al., 1989; ~
~ et al., 1991).
~
H
h ~ it is ~ suggesting
~ ~ that~ an increase
~~
~ protein
,
itranscrip- ~
tional
efficiency
and
synthetic
capacity
of
cardiac
difficult to conceive how this change could cause the
tissue
may
account
for
the
slight
changes
in
weight.
increased muscle growth noted in this study. In
Commonly, chronic BAA treatment has decreased
agreement with the calpain-calpastatin findings, our
liver weight (Reeds et al., 1986; Kim et al., 1987;
urea
data
suggest that the
Williams et al., 1989; Maloney et al., 1990;
proteolytic
rabbit
is
Muramatsu et al., 1991). Our data agree, exceptthat
unchanged
BAA treatment. The
and P liver weight in the BAA-treated rabbits increased
c a l ~ a i ndata in this study do not agree with the
after 1 d of treatment (Table 1 ) . According to the
findings of ~ o r s b e r get al. (1989), who fed BAA to
hypothesis, in muscle, that calpastatin activity is
rabbits for a prolonged period.
researchers
related to tissue size, then calpastatin activity in liver
should decrease after 16 d of BAA treatment. H ~ ~
reported that cimaterol treatment decreased the
activity of skeletal muscle calpastatin and pcalpain.
ever, in this study there were no BAA-induced
These discrepancies may be partially due to differresponses in either liver m-calpain or calpastatin
ences in the length of BAA treatment. Their data must
activities or in the concentrations of nucleic acids or
also be interpreted with caution, because frozen
protein, suggesting the lack of a clear relationship
samples were used to measure the calpain-calpastatin
between any of the variables measured and liver size
system and Koohmaraie (1990), Sainz et al. (1992),
in BAA-fed rabbits. The changes in liver weight may
and Whipple and Koohmaraie (1992) have since
simply be a reflection of the changes in tissue blood
reported that freezing of skeletal muscle decreased
flow that accompany BAA supplementation. Eisemann
et al. (1988) reported that heart rate and blood flow
calpastatin and pcalpain activities.
Were
increased by acute BAA treatment, whereas
The BAA-induced increase in RNA concentration
chronic
treatment shunted blood flow to the musculaand content and RNA:DNA ratio are consistent with
ture
of
the animal. Another possibility for the
results of previous studies (Beermann et al., 1987;
decreased liver weights is a decrease in the fractional
Forsberg et al., 1989; Williams et al., 1989; Koohprotein synthesis rates, as reported by Muramatsu et
maraie et al., 1991; Pringle et al., 1993). Changes in
al. ( 199
muscle weight appear after the RNA concentration
and RNA:DNA ratio begin to attenuate. It seems that
the protein synthetic capacity is higher in the BAAImplications
treated muscle, but it is unclear why the RNA
measurements seem to peak before detectible changes
A better understanding of the regulation of
in muscle weight. Collectivel~,these data suggest an
muscle, heart,, and liver growth could allow enhanced
alternative mechanism for BAA-hluced muscle
growth eficiency of meat animals through exogenous
growth in rabbits. The muscle data suggest that BAAalteration of these tissues. It seems that rabbits fed a
0-adrenergic agonist respond differently than do
induced muscle growth in rabbits occurs a t least
partially through a hyperplastic mechanism, whereby
sheep, offering another avenue for study of the
muscle protein synthetic capacity is elevated. This is
processes controlling tissue growth. Although these
contrary to the strictly hypertrophic mechanism
data are not conclusive as to a mechanism for /3reported in sheep and cattle, whereby protein degradaadrenergic-agonist-induced tissue growth in rabbits,
tion is generally lowered, and concurs with the
they offer direction for future considerations into the
study of the mechanism of action of 0-adrenergic
ruminant-specific effect of BAA-supplementation menagonists.
tioned by Bardsley et al. (1992).
To our knowledge, this is the first study to report
the effects of BAA treatment on the calpain-calpastaLiterature Cited
tin system in hepatic and cardiac tissues. The effects
of BAA treatment on heart weight vary, with inAnderson, D. B., E. L. Veenhuizen, D. J. Jones, A. L. Schroeder, and
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